# Research Alliance Holdings III LLC /Cayman — merger/spac_merger [pending]
Source: SEC API (secapi.ai) · situation sit_b882d7aef74b7e8f7e4a · retrieved 2026-08-11T15:53:10.787Z

## Overview
Research Alliance Corporation III is a blank-check company incorporated in the Cayman Islands that serves as a special purpose acquisition vehicle (SPAC) sponsored by Research Alliance Holdings III LLC.

On July 26, 2026, Research Alliance Corporation III (a Cayman Islands blank-check company) entered into a Business Combination Agreement with OHB Pediatrics Ltd. (a UK-incorporated company) and its shareholders to acquire 100% of OHB Pediatrics in exchange for newly issued shares of RACC Common Stock. The transaction values OHB Pediatrics at a base equity value of $160,000,000, with the Adjusted Equity Value also including the Company SAFE Amount (interim financing of $45,000,000 at 8% per annum provided by RA Capital Healthcare Fund, L.P. and RA Capital Nexus Fund IV, L.P.). The number of RACC Common Stock shares to be issued equals the Adjusted Equity Value divided by $10.00 per share. The transaction is expected to close in the second half of 2026, subject to shareholder approval, HSR clearance, Nasdaq listing approval, and other customary closing conditions. At closing, the Issuer will domesticate from the Cayman Islands to Delaware, with Class B ordinary shares converting to Class A on a one-for-one basis, and all Class A shares converting to RACC Common Stock.

## Terms
- Counterparty: OHB Pediatrics Ltd. · Deal value: $160.0M · Consideration: stock · Stake: 100% · Price/share: $10

## Key dates
- Announced 2026-07-28

## Timeline
- 2026-07-28 · SCHEDULE 13D/A (0002135648-26-000011): SCHEDULE 13D/A - Research Alliance Holdings III LLC /Cayman — *Research Alliance Corporation III is a blank-check company incorporated in the Cayman Islands that serves as a special purpose acquisition vehicle (SPAC) sponsored by Research Alliance Holdings III LLC.* On July 26, 2026, Research Alliance Corporation III (a Cayman Islands blank-check company) entered into a Business Combination Agreement with OHB Pediatrics Ltd. (a UK-incorporated company) and its shareholders to acquire 100% of OHB Pediatrics in exchange for newly issued shares of RACC Common Stock. The transaction values OHB Pediatrics at a base equity value of $160,000,000, with the Adjusted Equity Value also including the Company SAFE Amount (interim financing of $45,000,000 at 8% per annum provided by RA Capital Healthcare Fund, L.P. and RA Capital Nexus Fund IV, L.P.). The number of RACC Common Stock shares to be issued equals the Adjusted Equity Value divided by $10.00 per share. The transaction is expected to close in the second half of 2026, subject to shareholder approval, HSR clearance, Nasdaq listing approval, and other customary closing conditions. At closing, the Issuer will domesticate from the Cayman Islands to Delaware, with Class B ordinary shares converting to Class A on a one-for-one basis, and all Class A shares converting to RACC Common Stock.
  https://www.sec.gov/Archives/edgar/data/2135648/0002135648-26-000011.txt

## Citations
- 0002135648-26-000011 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000213564826000011